DCM Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.18M | Buy |
27,915
+2,059
| +8% | +$382K | 2.22% | 21 |
|
|
2025
Q1 | $5.41M | Sell |
25,856
-3,017
| -10% | -$631K | 2.89% | 15 |
|
|
2024
Q4 | $5.13M | Buy |
28,873
+1,078
| +4% | +$192K | 2.41% | 17 |
|
|
2024
Q3 | $5.49M | Hold |
27,795
| – | – | 2.77% | 16 |
|
|
2024
Q2 | $4.77M | Sell |
27,795
-4,486
| -14% | -$769K | 2.52% | 19 |
|
|
2024
Q1 | $5.88M | Sell |
32,281
-7,804
| -19% | -$1.42M | 2.42% | 18 |
|
|
2023
Q4 | $6.21M | Buy |
40,085
+5,447
| +16% | +$844K | 2.23% | 19 |
|
|
2023
Q3 | $5.16M | Sell |
34,638
-949
| -3% | -$141K | 2.33% | 18 |
|
|
2023
Q2 | $4.79M | Buy |
35,587
+488
| +1% | +$65.7K | 2.05% | 18 |
|
|
2023
Q1 | $5.59M | Sell |
35,099
-263
| -0.7% | -$41.9K | 2.6% | 16 |
|
|
2022
Q4 | $5.71M | Buy |
35,362
+13,725
| +63% | +$2.22M | 2.77% | 15 |
|
|
2022
Q3 | $2.9M | Sell |
21,637
-377
| -2% | -$50.6K | 1.46% | 14 |
|
|
2022
Q2 | $3.37M | Buy |
22,014
+1,040
| +5% | +$159K | 1.46% | 12 |
|
|
2022
Q1 | $3.4M | Sell |
20,974
-220
| -1% | -$35.7K | 1.2% | 18 |
|
|
2021
Q4 | $2.87M | Buy |
21,194
+9,910
| +88% | +$1.34M | 0.85% | 29 |
|
|
2021
Q3 | $1.22M | Buy |
+11,284
| New | +$1.22M | 0.47% | 56 |
|